AGLagilon health, inc.
$89.58+271% 1Y
$89.58
$7.9152 weeks$129.35
Is the price fair?
What AGL's price assumes
agilon health, inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 0.25× revenue.
0.25
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 6.61
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 0.24
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 6.61
- EV / EBIToperating margin −5.2%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 0.24
- Market capitalisation16.8 million shares, counted Jul 30, 2026
- $1.50B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.